本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、 监事会会议召开情况 中农立华生物科技股份有限公司（以下简称"公司"）第五届监事会第十二 次会议通知和会议材料已于 2023 年 10 月 17 日以电子邮件方式向全体监事发出， 本次会议于 2023 年 10 月 27 日在公司会议室以现场结合通讯表决方式召开。本 次会议由公司监事会主席主持，会议应出席监事 6 人，实际参会监事 6 人。本次 会议的召集、召开、表决程序符合《中华人民共和国公司法》《中农立华生物科 技股份有限公司章程》的有关规定，会议决议合法有效。 证券代码：603970 证券简称：中农立华 公告编号：2023-026 中农立华生物科技股份有限公司 第五届监事会第十二次会议决议公告 （二）审议通过《关于公司为子公司提供担保计划的议案》 1 具体内容详见公司于同日在上海证券交易所网站（www.sse.com.cn）发布的 《中农立华生物科技股份有限公司关于为子公司提供担保计划的公告》（公告编 号：2023-027）。 本议案需提交公司股东大会审议。 表决结果： ...

证券代码：603970 证券简称：中农立华 公告编号：2023-024 被担保人名称：爱格（上海）生物科技有限公司（以下简称"上海爱格"）。 本次担保金额及已实际为其提供的担保余额：公司对上海爱格提供向平安 银行申请综合授信提供连带责任担保，担保的授信额度最高额为人民币 1 亿元； 截至本公告披露日，公司已实际为上海爱格提供的担保余额为人民币 1 亿元（含 本次）。 本次担保是否有反担保：无。 为子公司提供担保逾期的累计数量：无。 一、担保情况概述 中农立华生物科技股份有限公司 关于为子公司提供担保的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 二、被担保人基本情况 1. 被担保人情况 公司名称：爱格（上海）生物科技有限公司 统一社会信用代码：91310107301434662B 注册地址：中国（上海）自由贸易试验区临港新片区海洋一路 313、333 号 孵化楼 1 第 4 层 412 室 根据公司业务发展需要，近日，中农立华生物科技股份有限公司（以下简称 "中农立华"或"公司"）对控股子公司上海爱 ...

证券代码：603970 证券简称：中农立华 公告编号：2023-025 （一）审议通过《关于公司<2023 年第三季度报告>的议案》 具体内容详见公司于同日在上海证券交易所网站（www.sse.com.cn）发布的 《中农立华生物科技股份有限公司 2023 年第三季度报告》。 表决结果：同意 9 票，反对 0 票，弃权 0 票。 （二）审议通过《关于公司为子公司提供担保计划的议案》 具体内容详见公司于同日在上海证券交易所网站（www.sse.com.cn）发布的 《中农立华生物科技股份有限公司关于为子公司提供担保计划的公告》（公告编 号：2023-027）。 中农立华生物科技股份有限公司 第五届董事会第二十九次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 中农立华生物科技股份有限公司（以下简称"公司"）第五届董事会第二十 九次会议通知和会议材料已于 2023 年 10 月 17 日以电子邮件方式向全体董事发 出，本次会议于 2023 年 10 月 27 日在公司会议室以现场结合通讯表决方 ...

证券代码：603970 证券简称：中农立华 公告编号：2023-027 中农立华生物科技股份有限公司 关于为子公司提供担保计划的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 被担保人名称: 爱格（新加坡）生物科技有限公司（SINO AGRI BIOSCIENCES SINGAPORE PTE.LTD.）（以下简称"新加坡公司"） 本次担保金额：预计为新加坡公司提供担保，额度折合人民币不超过 3 亿元。 本次担保是否有反担保：是。 对外担保逾期的累计数量：无。 特别风险提示：新加坡公司资产负债率超过 70%。本次反担保措施尚未办 理股权质押登记等相关手续，办理过程中可能存在无法办理工商股权质押登记的 风险以及政策法律变化等不可预见因素的影响，敬请广大投资者谨慎投资，注意 投资风险。 额度折合人民币不超过 3 亿元，担保方式包括但不限于保证、抵押或质押，本次 担保计划的授权有效期为本事项经股东大会审议通过之日起 12 个月。反担保措 施为上海爱格的少数股东南京科农生物科技合伙企业（有限合伙）、济南信博投 资 ...

证券代码：603970 证券简称：中农立华 中农立华生物科技股份有限公司 投资者关系活动记录表 编号：2023-02 ☑特定对象调研 £分析师会议 ☑媒体采访 £业绩说明会 投资者关 系活动类 £新闻发布会 ☑路演活动 别 ☑现场参观 ☑网络会议 ☑一对一沟通 £其他 参与单位 海通证券股份有限公司 李智 名称及人 中融基金管理有限公司 吴刚 员姓名 ...

证券代码:603970 证券简称:中农立华 中农立华生物科技股份有限公司 投资者关系活动记录表 编号:2023-02 ☑特定对象调研 分析师会议 ☑媒体采访 业绩说明会 投资者关 系活动类 别 新闻发布会 ☑路演活动 ☑现场参观 ☑网络会议 ☑一对一沟通 其他 海通证券股份有限公司 李智 中融基金管理有限公司 吴刚 中国国际金融股份有限公司 吴頔 财通证券股份有限公司 余剑秋、王宇璇、肖珮菁 财通基金管理有限公司 沈犁 天风证券股份有限公司 吴立、林逸丹 参与单位 名称及人 员姓名 宏利基金管理有限公司 周少博 新供销产业发展基金管理有限责任公司 申景奇 山西证券股份有限公司上海分公司 杨杰 长信基金管理有限责任公司 齐菲、沈佳 太平资产管理有限公司 陈祺麒 招银理财有限责任公司 张旭欣、杨鈜毅 兴证全球基金管理有限公司 李楠竹 | --- | --- | |--------------------------------|----------------| | 兴银基金管理有限责任公司 | 石亮 | | 摩根士丹利华鑫基金管理有限公司 | 孙人杰 | | 东北证券股份有限公司 | 王玮、陈科诺 | | 中泰 ...

Financial Performance - The company reported a total revenue of RMB 1.2 billion for the first half of 2023, representing a year-on-year increase of 15%[1]. - The net profit attributable to shareholders reached RMB 300 million, up 20% compared to the same period last year[1]. - The company's operating revenue for the first half of 2023 was approximately ¥6.29 billion, representing a 3.15% increase compared to the same period last year[23]. - Net profit attributable to shareholders for the same period was approximately ¥152.28 million, reflecting a 9.56% year-over-year growth[23]. - The basic earnings per share for the first half of 2023 was ¥0.5665, up 9.55% from ¥0.5171 in the previous year[24]. - The total comprehensive income for the first half of 2023 was CNY 170,505,244.85, compared to CNY 158,904,968.10 in the same period of 2022, representing a growth of 7.5%[131]. - The total profit for the first half of 2023 was CNY 222,241,938.87, up from CNY 209,321,737.55, reflecting a growth of 6.3% year-over-year[130]. Market Expansion and Strategy - The company has set a revenue guidance of RMB 2.5 billion for the full year 2023, reflecting an expected growth of 10%[1]. - The company is expanding its market presence in Southeast Asia, targeting a 15% market share by the end of 2024[1]. - The company has established subsidiaries in several countries, including Colombia and Singapore, to expand its export trade in raw materials and formulations[34]. - The company operates in over 90 countries and regions, focusing on pesticide product registration and establishing a stable supply chain for international markets[35]. - The company has formed strategic partnerships with leading international pesticide firms, enhancing its product variety and market reach[42]. Research and Development - Research and development expenses increased by 18%, focusing on innovative biotech solutions for crop protection[1]. - New product launches contributed to 30% of total sales, with significant demand for the latest agricultural technology solutions[1]. - The company introduced new products such as "Yuying," "Jingjinkairui," "Yeshifu," and "Meipeng" to enhance crop health solutions[48]. - Research and development expenses surged by 124.62% to CNY 25,729,950.98, reflecting increased investment in innovation[52]. Financial Position and Cash Flow - The company maintains a strong cash position with cash reserves of RMB 500 million, ensuring liquidity for future investments[1]. - The net cash flow from operating activities was negative at approximately -¥935.90 million, indicating a significant decline compared to the previous year[23]. - The company's total assets at the end of the reporting period were approximately ¥5.74 billion, a decrease of 8.07% from the previous year-end[23]. - Cash and cash equivalents decreased significantly from CNY 1,931,722,075.70 to CNY 494,270,365.02, a drop of approximately 74.4%[118]. - The company reported a significant increase in accounts receivable, rising by 677.56% to CNY 1,955,859,215.42[55]. Risks and Challenges - The management highlighted potential risks including regulatory changes and market competition, which could impact future performance[1]. - The company faces intensified market competition as the pesticide industry undergoes structural adjustments and transformations, with competitors having strong financial backing[70]. - The company has implemented strict procurement processes, but there is still a risk of product quality issues that could lead to claims or lawsuits, affecting its reputation and financial performance[70]. Corporate Governance and Management - The company has appointed new senior management, including Huang Baiji as General Manager and Li Mingguang as Executive Vice President, following the resignation of previous executives[75]. - The company does not plan to distribute profits or increase capital reserves in the first half of 2023, with no dividends or stock bonuses proposed[77]. Environmental and Social Responsibility - The company is actively reducing carbon emissions by limiting the operation of older vehicles and treating volatile organic compounds from pesticide production[81]. - The company is committed to ensuring a stable supply of pesticides to support rural revitalization efforts[82]. - The company signed supply cooperation agreements with 150 major pesticide manufacturers to ensure a stable supply chain for agricultural production in the first half of 2023[83]. Shareholder Information - The largest shareholder, China Agricultural Supply Materials Group Co., Ltd., holds 135,072,000 shares, representing 50.25% of the total shares[110]. - The company reported a profit distribution of approximately -124.92 million, indicating a significant loss compared to the previous period[146]. - The total owner's equity at the end of the first half of 2023 was ¥1,317,736,743.44, reflecting a decrease from the previous period[158].

本次会计政策变更是中农立华生物科技股份有限公司（以下简称"公 司""本公司"）根据中华人民共和国财政部（以下简称"财政部"）颁布的《企 业会计准则解释第 16 号》（财会〔2022〕31 号，以下简称"《准则解释第 16 号》"） 的要求，对公司会计政策、相关会计科目核算和列报进行适当的变更和调整。 中农立华生物科技股份有限公司 关于会计政策变更的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、概述 2022年11月30日，财政部发布了《准则解释第16号》，明确规定"关于单项 交易产生的资产和负债相关的递延所得税不适用初始确认豁免的会计处理"等内 容。本公司自2023年1月1日起执行"关于单项交易产生的资产和负债相关的递延 所得税不适用初始确认豁免的会计处理"的规定。 二、会计政策变更的具体情况及对公司的影响 证券代码：603970 证券简称：中农立华 公告编号：2023-022 内容自2023年1月1日起施行。 （二）本次会计政策变更主要内容 本次会计政策变更前，公司执行财政部颁布的《企业会计准则— ...

证券代码：603970 证券简称：中农立华 中农立华生物科技股份有限公司 投资者关系活动记录表 编号：2023-01 ☑特定对象调研 分析师会议 媒体采访 业绩说明会 投资者关 系活动类 别 新闻发布会 路演活动 ☑现场参观 ☑网络会议 ☑一对一沟通 其他 财通证券股份有限公司 余剑秋、王宇璇、费津皖 天风证券股份有限公司 林逸丹、刘思远 广东弘信达私募股权投资基金管理有限公司 黄文希 参与单位 名称及人 员姓名 大成基金管理有限公司 韩创 中金公司资产管理部 彭祺程 富国基金管理有限公司 蒲世林 长信基金管理有限责任公司 许望伟、齐菲 时间 2023 年 4 月 19 日、5 月 8 日、5 月 16 日、5 月 17 日、5 月 19 日、5 月 22 日、5 月 31 日、6 月 6 日 地点 中农立华会议室、线上会议 上市公司 接待人员 姓名 公司总经理兼董事会秘书黄柏集先生 公司党总支部副书记、副总经理及证券事务代表常青女士 1.管理层介绍公司情况 中农立华是中华全国供销合作总社下属唯一农化流通上市平台。 公司自 2009 年从中国农业生产资料集团有限公司（以下简称"中农 集团"）农药部改制成立，2 ...

Financial Performance - In 2022, the company achieved a net profit of RMB 148,250,292.47, with total distributable profits amounting to RMB 645,855,331.11 after accounting for dividends and reserves[6]. - The proposed cash dividend is RMB 5.50 per 10 shares, totaling RMB 105,600,052.80, which represents 50.21% of the net profit for the year[7]. - The company's operating revenue for 2022 was CNY 11.698 billion, representing a 32.61% increase compared to CNY 8.822 billion in 2021[26]. - The net profit attributable to shareholders for 2022 was CNY 210.333 million, a 23.50% increase from CNY 170.309 million in 2021[26]. - The net profit after deducting non-recurring gains and losses was CNY 198.936 million, up 24.77% from CNY 159.439 million in 2021[26]. - The net cash flow from operating activities reached CNY 1.536 billion, a significant increase of 371.89% compared to CNY 325.419 million in 2021[26]. - The total assets at the end of 2022 were CNY 6.244 billion, reflecting a 31.68% increase from CNY 4.742 billion at the end of 2021[26]. - The basic earnings per share for 2022 was CNY 1.0952, up 23.51% from CNY 0.8870 in 2021[27]. - The weighted average return on equity increased to 16.91% in 2022 from 15.63% in 2021[28]. Risk Management - The company has not identified any significant risks that could materially affect its operations during the reporting period[10]. - The company emphasizes the importance of risk awareness in its forward-looking statements, advising investors to consider potential investment risks[8]. - The company has not faced any violations in decision-making procedures regarding external guarantees[9]. - The company has committed to ensuring the accuracy and completeness of its financial reports, as confirmed by the external auditor's standard unqualified opinion[5]. Strategic Development - The company has a comprehensive strategy for future development, although specific details are not disclosed in the summary[10]. - The company launched new products such as "Zhongnong Jingzhi," "Daqi," and "Youzuo," with significant sales performance, including over CNY 100 million in sales for the "Fuliya" product[36]. - The company expanded its international business by enhancing core product sales and implementing brand renewal projects in international markets[37]. - The company is committed to optimizing its product structure and reducing costs, with ongoing research and development of new agricultural machinery products[37]. - The company aims to enhance operational capabilities and service efficiency through logistics information upgrades and customer engagement[37]. Market Conditions - The raw material price index reported a decline of 32.7% year-on-year as of December 25, 2022, with 79% of product prices decreasing, impacting the agricultural chemical industry[38]. - The company faced challenges in the agricultural chemical market due to supply exceeding demand, leading to a significant drop in raw material transaction volumes[39]. - The demand for pesticides is expected to remain stable due to the emphasis on food security amid global political instability and rising international grain prices[89]. - The domestic pesticide market is anticipated to see increased concentration and intensified competition, with stronger companies expanding upstream and downstream[90]. Corporate Governance - The company has no penalties from securities regulatory agencies in the past three years[113]. - The company has no significant issues in corporate governance as per the self-inspection conducted[139]. - The company has established an incentive mechanism for core management and key employees as discussed in the board meeting on August 18, 2022[114]. - The total remuneration for all directors, supervisors, and senior management personnel at the end of the reporting period was 8.0387 million yuan[111]. Research and Development - The company is committed to research and development in new technologies to improve agricultural practices and product offerings[106]. - Research and development expenses rose to ¥45,785,963.73, marking a 22.01% increase from ¥37,527,549.23 in the prior year[55]. - The total R&D expenditure accounted for 0.39% of the operating revenue, with no capitalized R&D expenses reported[65]. - The number of R&D personnel is 145, accounting for 16.84% of the total workforce[66]. Social Responsibility - The company has invested ¥36.79 million in environmental protection during the reporting period[140]. - The company conducted over 10,100 technical training service activities in 2022 to support farmers with pest control solutions[146]. - The company donated a total of CNY 300,000 to educational institutions, including CNY 200,000 to Jilin Agricultural University and CNY 100,000 to Yangtze University[145]. - The company is actively promoting the "green agricultural materials" initiative by introducing efficient, low-toxicity products and enhancing recycling efforts[146]. Financial Management - The company has a cash dividend policy that ensures a minimum distribution of 20% of the distributable profit each year, with a total cash dividend amount of ¥105,600,052.80, accounting for 50.21% of the net profit attributable to ordinary shareholders[134][135]. - The company has a total of 1 billion RMB in bank wealth management, with an outstanding balance of 1 billion RMB[173]. - The company has successfully recovered all structured deposits, indicating effective cash management strategies[176]. - The company has engaged in cash asset management through entrusted wealth management, indicating a proactive approach to asset growth[172]. Employee Management - The company has implemented training programs for employees, combining internal and external training methods, including remote video conferencing for dispersed staff[130]. - The company has established a competitive salary and bonus structure to attract and retain talent, with performance incentives linked to annual performance goals[128]. - The total number of employees in the parent company and major subsidiaries is 861, with 257 in the parent company and 604 in subsidiaries[127]. - The company has a total of 861 employees, with 489 holding a bachelor's degree or higher[127].